Company profileNutraceutical & supplements#249 of 1,318 in Pakistan1 DRAP alert

Sidaz Health Foods, Hyderabad

Nutraceutical & supplement manufacturer · 73 registered products

73 registered products 3 distinct molecules 1 DRAP alert

73 of this company's registrations sit in the DRAP category “Nutritional Supplement / Multivitamin”, which is registered as a category rather than by molecule — so a low molecule count reflects how supplements are registered, not a small portfolio. Nutraceutical manufacturers advertise direct to consumers and are among the largest marketing spenders in the Pakistani market.

Company overview

registered products

distinct molecules

therapeutic classes

DRAP alerts

Sidaz Health Foods, Hyderabad is a nutraceutical and dietary-supplement manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 73 product registrations. DRAP has issued 1 alert involving its products.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Top molecules by brand count

Nutritional Supplement / Multivitamin73 brands

Norethisterone1 brand

Ceftriaxone1 brand

Regulatory record

1 alert in the DRAP feed we track.

Voluntary Recall Alert: Drug Product; Meronem 1g Injection (Batch #4A20B27 and Batch # 4A2

2022-06-02

Competitive set

Companies whose registered portfolio overlaps most with this one.

LIBRA PHARMACEUTICALS (PVT) LTD1 shared molecules

ZAFA PHARMACEUTICAL LABORATORIES (PVT) LTD.1 shared molecules

MASS PHARMA (PRIVATE) LIMITED1 shared molecules

REGENT LABORATORIES LTD.1 shared molecules

Pakistan Herbal Pharma, Faisalabad1 shared molecules

GLOBAL BRANDS DISTRIBUTORS1 shared molecules

MEDICRAFT PHARMACEUTICALS (PVT) LTD.1 shared molecules

HYGEIA PHARMACEUTICALS1 shared molecules

GEOFMAN PHARMACEUTICALS1 shared molecules

KRKA-PAK PHARMACEUTICAL & CHEMICAL WORKS1 shared molecules

Get the full profile for Sidaz

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included